Olympiad Research’s Genpact G Stock Holding History

Olympiad Research’s Portfolio G Stock Details G Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-7,275	Closed	-$234K	–	384
2024 Q2	$234K	Sell	7,275 -4,392	-38%	-$142K	0.17%	235
2024 Q1	$384K	Buy	+11,667	New	+$405K	0.25%	132
2023 Q3	–	Sell	-5,884	Closed	-$221K	–	347
2023 Q2	$221K	Buy	+5,884	New	+$237K	0.22%	194
2022 Q2	–	Sell	-6,847	Closed	-$298K	–	305
2022 Q1	$298K	Buy	+6,847	New	+$317K	0.09%	197

Other funds holding G

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NIEF

Nalanda India Equity Fund Mauritius $510M AUM 23.61% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Olympiad Research's G Position: Q3 2024 in Review

Olympiad Research sold out of Genpact (G) in Q3 2024, closing a stake of 7,275 shares — an estimated $234K sold.

Olympiad Research first reported a position in G in Q1 2022 and held it in 4 quarters. The position peaked at $384K in Q1 2024. 385 funds tracked by Wall St. Rank hold G as of Q3 2024.

Olympiad Research reported no remaining Genpact position as of Q3 2024 after selling out during the quarter.
Olympiad Research sold 7,275 Genpact shares in Q3 2024, an estimated $234K.
Olympiad Research first reported a position in Genpact in Q1 2022 and held it in 4 quarters.
Olympiad Research's Genpact position peaked at $384K in Q1 2024.
385 funds tracked by Wall St. Rank held Genpact as of Q3 2024.

Based on Olympiad Research's 13F filing for Q3 2024, filed 31 Oct 2024.